Skip to main content
. 2021 Mar 26;16:60. doi: 10.1186/s13014-021-01791-9

Table 4.

Follow-up and toxicity

Patient 1 (LMU) Patient 2 (LMU) Patient 3 (LMU) Patient 4 (A. Gemelli)
Time from last RT to follow up (months) 6 6 3 1
Local control Yes Yes n.a Yes
Metastases No Yes, mediastinal lymphnode metastases, liver metastases n.a [Yes, from melanoma]
Toxicity at first follow-up

Fatigue CTCAE °1

Dyspnea CTCAE °1

Fatigue CTCAE °2

Dyspnea CTCAE °2

Chest pain CTCAE °1

None

Fatigue CTCAE °2

Dyspnea CTCAE °2